CRISTINA BOLIN: Open Payments
NPI 1790224699 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 42 payments from 12 companies in 2025. Trend: 2023 $618 · 2024 $658 · 2025 $1,008
Food & beverage: $918Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $276 |
| Novo Nordisk Inc | 14 | $216 |
| Lilly USA, LLC | 5 | $136 |
| Amgen Inc. | 3 | $70 |
| Exact Sciences Corporation | 3 | $67 |
| Dexcom, Inc. | 2 | $56 |
| ABBVIE INC. | 2 | $39 |
| Abbott Laboratories | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
Products named: AIRSUPRA, FARXIGA, Ozempic, Wegovy, Cologuard Collection Kit, Dexcom G6 Transmitter, OTEZLA, QULIPTA.
Industry payments across KY — which companies pay providers there.
